These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9789220)

  • 1. Loss of heterozygosity on chromosome 6q27 and p53 mutations in epithelial ovarian cancer.
    Suzuki M; Saito S; Saga Y; Ohwada M; Sato I
    Med Oncol; 1998 Jul; 15(2):119-23. PubMed ID: 9789220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation of K-RAS protooncogene and loss of heterozygosity on 6q27 in serous and mucinous ovarian carcinomas.
    Suzuki M; Saito S; Saga Y; Ohwada M; Sato I
    Cancer Genet Cytogenet; 2000 Apr; 118(2):132-5. PubMed ID: 10748293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelotype analysis of common epithelial ovarian cancers with special reference to comparison between clear cell adenocarcinoma with other histological types.
    Okada S; Tsuda H; Takarabe T; Yoshikawa H; Taketani Y; Hirohashi S
    Jpn J Cancer Res; 2002 Jul; 93(7):798-806. PubMed ID: 12149146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary.
    Fujita M; Enomoto T; Inoue M; Tanizawa O; Ozaki M; Rice JM; Nomura T
    Jpn J Cancer Res; 1994 Dec; 85(12):1247-56. PubMed ID: 7852189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity in P53, BRCA1, and estrogen receptor genes and correlation to expression of p53 protein in ovarian epithelial tumors of different cell types and biological behavior.
    Otis CN; Krebs PA; Quezado MM; Albuquerque A; Bryant B; San Juan X; Kleiner D; Sobel ME; Merino MJ
    Hum Pathol; 2000 Feb; 31(2):233-8. PubMed ID: 10685639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.
    Bignone PA; Lee KY; Liu Y; Emilion G; Finch J; Soosay AE; Charnock FM; Beck S; Dunham I; Mungall AJ; Ganesan TS
    Oncogene; 2007 Feb; 26(5):683-700. PubMed ID: 16878154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 mutation is infrequent in clear cell carcinoma of the ovary.
    Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
    Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 mutation in epithelial ovarian carcinoma and borderline ovarian tumor.
    Lee JH; Kang YS; Park SY; Kim BG; Lee ED; Lee KH; Park KB; Kavanagh JJ; Wharton JT
    Cancer Genet Cytogenet; 1995 Nov; 85(1):43-50. PubMed ID: 8536236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas.
    Uehara Y; Oda K; Ikeda Y; Koso T; Tsuji S; Yamamoto S; Asada K; Sone K; Kurikawa R; Makii C; Hagiwara O; Tanikawa M; Maeda D; Hasegawa K; Nakagawa S; Wada-Hiraike O; Kawana K; Fukayama M; Fujiwara K; Yano T; Osuga Y; Fujii T; Aburatani H
    PLoS One; 2015; 10(6):e0128066. PubMed ID: 26043110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas.
    Choi C; Cho S; Horikawa I; Berchuck A; Wang N; Cedrone E; Jhung SW; Lee JB; Kerr J; Chenevix-Trench G; Kim S; Barrett JC; Koi M
    Genes Chromosomes Cancer; 1997 Nov; 20(3):234-42. PubMed ID: 9365830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis.
    Xu B; Hamada S; Kusuki I; Itoh R; Kitawaki J
    Gynecol Oncol; 2011 Feb; 120(2):239-46. PubMed ID: 21130491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of loss of heterozygosity at chromosome 3p25-26 in primary and metastatic ovarian clear-cell carcinoma: utilization of microdissection and polymerase chain reaction in archival tissues.
    Simsir A; Palacios D; Linehan WM; Merino MJ; Abati A
    Diagn Cytopathol; 2001 May; 24(5):328-32. PubMed ID: 11335962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome 6p21.2, 18q21.2 and human papilloma virus (HPV) DNA can predict prognosis of cervical cancer after radiotherapy.
    Harima Y; Sawada S; Nagata K; Sougawa M; Ohnishi T
    Int J Cancer; 2001 Oct; 96(5):286-96. PubMed ID: 11582581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity at chromosome 9q22-31 is a frequent and early event in ovarian tumors.
    Byrom J; Mudaliar V; Redman CW; Jones P; Strange RC; Hoban PR
    Int J Oncol; 2004 May; 24(5):1271-7. PubMed ID: 15067351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 expression, mutation, and allelic deletion in ovarian cancer.
    McManus DT; Yap EP; Maxwell P; Russell SE; Toner PG; McGee JO
    J Pathol; 1994 Nov; 174(3):159-68. PubMed ID: 7823248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors.
    Gras E; Cortes J; Diez O; Alonso C; Matias-Guiu X; Baiget M; Prat J
    Cancer; 2001 Aug; 92(4):787-95. PubMed ID: 11550149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of alterations in p73 gene, related to p53 at 1p36, in human hepatocellular carcinoma.
    Aoki T; Miyamoto A; Marubashi S; Nagano H; Umeshita K; Fujiwara Y; Dono K; Nakamori S; Sakon M; Monden M
    Int J Oncol; 2004 Feb; 24(2):441-6. PubMed ID: 14719122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
    Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
    Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of loss of heterozygosity of the tumor suppressor genes p53 and BRCA1 in ovarial carcinomas].
    Petrović B; Perović M; Novaković I; Atanacković J; Popović B; Luković L; Petković S
    Vojnosanit Pregl; 2006 Sep; 63(9):813-8. PubMed ID: 17039893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.